GeoVax Labs (GOVX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.24, -7.64% vs the prior close of $0.26.
- Volume 145.49K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GOVX slides 7.6% to $0.24, a 52-week low. Closed at $0.24, -7.64% vs the prior close of $0.26. Day range $0.23–$0.26, opened at $0.26.
GOVX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GOVX slides 7.6% to $0.24, a 52-week low
- Closed at $0.24, -7.64% vs the prior close of $0.26. Day range $0.23–$0.26, opened at $0.26.
- Volume was 145.49K shares, 0.2x its 50-day average of 941.20K — lighter than usual.
- Price is -50.1% vs its 50-day average ($0.48) and -83.7% vs its 200-day average ($1.46).
- 52-week range $0.23–$15.75; today's close sits at 0% of that range, 98.5% below the 52-week high.
Oct 15, 2026 — GOVX jumps 7.1% to $0.26
- Closed at $0.26, +7.05% vs the prior close of $0.24. Day range $0.23–$0.26, opened at $0.24.
- Volume was 598.50K shares, 0.6x its 50-day average of 931.90K.
- Price is -47.0% vs its 50-day average ($0.49) and -82.6% vs its 200-day average ($1.49).
- 52-week range $0.23–$15.75; today's close sits at 0% of that range, 98.4% below the 52-week high.
Oct 14, 2026 — GOVX slides 9.4% to $0.24, a 52-week low
- Closed at $0.24, -9.40% vs the prior close of $0.27. Day range $0.24–$0.28, opened at $0.28.
- Volume was 713.20K shares, 0.8x its 50-day average of 920.62K.
- Price is -51.5% vs its 50-day average ($0.50) and -84.0% vs its 200-day average ($1.51).
- 52-week range $0.24–$15.75; today's close sits at 0% of that range, 98.5% below the 52-week high.
Oct 13, 2026 — GOVX slides 5.7% to $0.27, a 52-week low
- Closed at $0.27, -5.67% vs the prior close of $0.28. Day range $0.26–$0.29, opened at $0.28.
- Volume was 226.20K shares, 0.2x its 50-day average of 921.05K — lighter than usual.
- Price is -47.6% vs its 50-day average ($0.51) and -82.6% vs its 200-day average ($1.53).
- 52-week range $0.26–$15.75; today's close sits at 0% of that range, 98.3% below the 52-week high.
Oct 12, 2026 — GOVX rises 0.4% to $0.28
- Closed at $0.28, +0.36% vs the prior close of $0.28. Day range $0.28–$0.30, opened at $0.30.
- Volume was 204.80K shares, 0.2x its 50-day average of 917.93K — lighter than usual.
- Price is -45.4% vs its 50-day average ($0.52) and -81.8% vs its 200-day average ($1.55).
- 52-week range $0.27–$15.75; today's close sits at 0% of that range, 98.2% below the 52-week high.
Oct 9, 2026 — GOVX dips 2.1% to $0.28, a 52-week low, 8 down days in a row
- Closed at $0.28, -2.09% vs the prior close of $0.29. Day range $0.27–$0.30, opened at $0.28.
- Volume was 233.10K shares, 0.3x its 50-day average of 915.23K — lighter than usual.
- Price is -46.4% vs its 50-day average ($0.52) and -82.1% vs its 200-day average ($1.57).
- 52-week range $0.27–$15.75; today's close sits at 0% of that range, 98.2% below the 52-week high.
- That makes 8 straight losses.
Oct 8, 2026 — GOVX dips 0.7% to $0.29, a 52-week low, 7 down days in a row
- Closed at $0.29, -0.69% vs the prior close of $0.29. Day range $0.28–$0.31, opened at $0.30.
- Volume was 316.70K shares, 0.3x its 50-day average of 910.90K — lighter than usual.
- Price is -46.1% vs its 50-day average ($0.53) and -82.0% vs its 200-day average ($1.59).
- 52-week range $0.28–$15.75; today's close sits at 0% of that range, 98.2% below the 52-week high.
- That makes 7 straight losses.
Oct 7, 2026 — GOVX ends flat (+0.0%) to $0.29, 6 down days in a row
- Closed at $0.29, +0.00% vs the prior close of $0.29. Day range $0.28–$0.31, opened at $0.30.
- Volume was 719.80K shares, 0.8x its 50-day average of 901.32K.
- Price is -46.6% vs its 50-day average ($0.54) and -82.0% vs its 200-day average ($1.61).
- 52-week range $0.28–$15.75; today's close sits at 0% of that range, 98.2% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — GOVX slides 9.7% to $0.29, a 52-week low on 1.9x normal volume
- Closed at $0.29, -9.69% vs the prior close of $0.32. Day range $0.28–$0.33, opened at $0.32.
- Volume was 1.63M shares, 1.9x its 50-day average of 872.16K — unusually heavy trading.
- Price is -47.4% vs its 50-day average ($0.55) and -82.4% vs its 200-day average ($1.64).
- 52-week range $0.28–$15.75; today's close sits at 0% of that range, 98.2% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — GOVX ends flat (+0.0%) to $0.32 on 17.9x normal volume
- Closed at $0.32, +0.00% vs the prior close of $0.32. Day range $0.31–$0.46, opened at $0.33.
- Volume was 11.58M shares, 17.9x its 50-day average of 648.95K — unusually heavy trading.
- Price is -42.8% vs its 50-day average ($0.56) and -80.8% vs its 200-day average ($1.67).
- 52-week range $0.31–$15.75; today's close sits at 0% of that range, 98.0% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — GOVX dips 0.6% to $0.32, a 52-week low, 3 down days in a row
- Closed at $0.32, -0.62% vs the prior close of $0.32. Day range $0.32–$0.33, opened at $0.32.
- Volume was 192.80K shares, 0.3x its 50-day average of 648.32K — lighter than usual.
- Price is -43.6% vs its 50-day average ($0.57) and -81.2% vs its 200-day average ($1.70).
- 52-week range $0.32–$15.75; today's close sits at 0% of that range, 98.0% below the 52-week high.
- That makes 3 straight losses.
GOVX latest news & SEC filings
Every SEC filing by or about GOVX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 17, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 10, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 31, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 27, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.43M (prior year -$5.37M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.97 (prior year -$8.74) (loss narrowed vs Jun 30, 2025)
Jul 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade GOVX
- Last results release: Jul 27, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Apr 15, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Oct 26, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.41% (largest 9.7%). That is a volatile stock.
- Liquidity: about 928.52K shares (≈$221.27K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.24 vs a range of $0.23–$15.75 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Jan 12, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: John N Jr Spencer bought 10,000 shares on Oct 17, 2025.
- Latest filings: 8-K Sep 10, 2026; 8-K Aug 28, 2026; 8-K Aug 28, 2026.
- Share count: 7.37M shares outstanding (Jul 27, 2026), -70.9% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
GOVX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.26 | 0.26 | 0.23 | 0.24 | 145.49K |
| Oct 15, 2026 | 0.24 | 0.26 | 0.23 | 0.26 | 598.50K |
| Oct 14, 2026 | 0.28 | 0.28 | 0.24 | 0.24 | 713.20K |
| Oct 13, 2026 | 0.28 | 0.29 | 0.26 | 0.27 | 226.20K |
| Oct 12, 2026 | 0.30 | 0.30 | 0.28 | 0.28 | 204.80K |
| Oct 9, 2026 | 0.28 | 0.30 | 0.27 | 0.28 | 233.10K |
| Oct 8, 2026 | 0.30 | 0.31 | 0.28 | 0.29 | 316.70K |
| Oct 7, 2026 | 0.30 | 0.31 | 0.28 | 0.29 | 719.80K |
| Oct 6, 2026 | 0.32 | 0.33 | 0.28 | 0.29 | 1.63M |
| Oct 5, 2026 | 0.33 | 0.46 | 0.31 | 0.32 | 11.58M |
| Oct 2, 2026 | 0.32 | 0.33 | 0.32 | 0.32 | 192.80K |
| Oct 1, 2026 | 0.33 | 0.34 | 0.32 | 0.32 | 121.80K |
| Sep 30, 2026 | 0.37 | 0.37 | 0.33 | 0.33 | 199.70K |
| Sep 29, 2026 | 0.36 | 0.36 | 0.34 | 0.35 | 284.10K |
| Sep 28, 2026 | 0.36 | 0.37 | 0.34 | 0.35 | 170.70K |
| Sep 25, 2026 | 0.37 | 0.38 | 0.35 | 0.35 | 229.80K |
| Sep 24, 2026 | 0.38 | 0.40 | 0.36 | 0.36 | 251.50K |
| Sep 23, 2026 | 0.36 | 0.39 | 0.36 | 0.38 | 268.80K |
| Sep 22, 2026 | 0.36 | 0.38 | 0.35 | 0.36 | 189.50K |
| Sep 21, 2026 | 0.37 | 0.37 | 0.35 | 0.36 | 289.20K |
About GeoVax Labs
GeoVax Labs (GOVX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SMYRNA, GA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 832489.
GOVX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Randal D Chase | Director | Jun 22, 2026 |
| David A Dodd | President, CEO | Jun 22, 2026 |
| Dean G Kollintzas | Director | Jun 22, 2026 |
| Nicole Lemerond | Director | Jun 22, 2026 |
| Robert T Mcnally | Director | Jun 22, 2026 |
| Jayne Morgan | Director | Jun 22, 2026 |
| John N Jr Spencer | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David A Dodd | President, CEO | Jun 22, 2026 |
| Kelly T. Jr. Mckee | Chief Medical Officer | Jun 22, 2026 |
| Mark J Newman | Chief Scientific Officer | Jun 22, 2026 |
| Mark Reynolds | CFO | Jun 22, 2026 |
| John W. Sharkey | VP, Business Development | Jun 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 17, 2025 | John N Jr Spencer | Buy | 10,000 | $0.55 |
| Oct 17, 2025 | John N Jr Spencer | Buy | 10,000 | $0.55 |
| Oct 17, 2025 | John N Jr Spencer | Buy | 10,000 | $0.55 |
| Oct 17, 2025 | John N Jr Spencer | Buy | 10,000 | $0.55 |
GOVX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-21.46M | -22.40 | $-21.47M |
| Dec 31, 2024 | — | $-24.99M | -120.46 | $-24.68M |
| Dec 31, 2023 | — | $-25.97M | -14.29 | $-25.17M |
| Dec 31, 2022 | — | $-14.02M | -12.39 | $-19.03M |
| Dec 31, 2021 | — | $-18.57M | -3.04 | $-11.20M |
Latest balance sheet: total assets $4.64M, total liabilities $2.88M, cash $3.14M (as of Jun 30, 2026).
GOVX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 27, 2026 | 8-K Item 2.02 (results) | $0.76 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.26 |
| Apr 15, 2026 | 8-K Item 2.02 (results) | $1.28 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $11.73 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $18.80 |
| May 1, 2025 | 8-K Item 2.02 (results) | $24.73 |
| Mar 28, 2025 | 8-K Item 2.02 (results) | $27.75 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $67.50 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GOVX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.